- Report
- November 2025
- 150 Pages
Global
From €5375EUR$5,950USD£4,664GBP
- Report
- February 2026
- 250 Pages
Global
From €4056EUR$4,490USD£3,520GBP
- Report
- July 2025
- 350 Pages
Global
From €4471EUR$4,949USD£3,879GBP
- Report
- June 2025
- 400 Pages
Global
From €4471EUR$4,949USD£3,879GBP
- Report
- August 2025
- 150 Pages
Global
From €4381EUR$4,850USD£3,802GBP
- Report
- April 2026
- 160 Pages
Global
From €3749EUR$4,150USD£3,253GBP
- Report
- November 2025
- 150 Pages
United States
From €3568EUR$3,950USD£3,096GBP
- Report
- July 2025
- 120 Pages
Global
From €5375EUR$5,950USD£4,664GBP
- Report
- June 2026
- 487 Pages
Global
From €5285EUR$5,850USD£4,586GBP
- Report
- June 2026
- 563 Pages
Global
From €5285EUR$5,850USD£4,586GBP
- Report
- November 2025
- 185 Pages
Global
From €4065EUR$4,500USD£3,527GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2519EUR$2,789USD£2,186GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2519EUR$2,789USD£2,186GBP
- Report
- April 2026
- 160 Pages
Global
From €3749EUR$4,150USD£3,253GBP
- Report
- March 2026
- 135 Pages
Global
From €4381EUR$4,850USD£3,802GBP
- Report
- February 2026
- 250 Pages
Global
From €4056EUR$4,490USD£3,520GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1355EUR$1,500USD£1,176GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1807EUR$2,000USD£1,568GBP
- Report
- June 2024
- 200 Pages
Global
From €7182EUR$7,950USD£6,232GBP
- Report
- June 2024
- 200 Pages
Global
From €7182EUR$7,950USD£6,232GBP

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more